Acne Treatment PrARAZLO™ Available Via BC PharmaCare
11 Apr 2024 //
ACCESSWIRE
Ortho Dermatologics to Present Data at 2022 Innovations Dermatology Conference
01 Nov 2022 //
ACCESSWIRE
Cosette Announces the Approval and Launch of First Generic Versions of TAZORAC
20 Sep 2022 //
BUSINESSWIRE
Cosette`s Generic Tazarotene Receives Approval in the U.S.
13 Sep 2022 //
FDA
FDA Confirms Para IV Patent Litigation for Tazarotene topical solution.
26 Jul 2022 //
FDA
Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology
19 Oct 2021 //
PRNEWSWIRE
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO™
13 Jan 2020 //
PR NEWSWIRE
Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis
26 Apr 2019 //
CNBC
Fougera Pharms`s Generic Tazarotene Receives Approval in US
28 Jan 2019 //
FDA
Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival
21 Nov 2018 //
FIERCE PHARMA
Almirall acquires Allergan U.S. medical dermatology portfolio
21 Sep 2018 //
PR NEWSWIRE
Bausch revives FDA quest for psoriasis hopeful Duobrii
31 Aug 2018 //
FIERCE PHARMA
Almirall acquires Allergan`s US dermatology portfolio for $650 million
03 Aug 2018 //
PHARMA TIMES
US FDA rejects Valeant’s Duobrii for plaque psoriasis
19 Jun 2018 //
IN PHARMATECHNOLOGY
FDA rejects Duobrii, a Valeant `Significant Seven` drug
19 Jun 2018 //
FIERCE PHARMA
Valeant nosedives on CRL for plaque psoriasis, raising concerns over touted $1B
18 Jun 2018 //
ENDPTS
Enforcement Report - Week of April 11, 2018
11 Apr 2018 //
FDA
G And W Labs Generic Tazarotene Receives Approval In US
27 Dec 2017 //
FDA
Taro`s Generic Tazarotene Receives Approval In US
06 Apr 2017 //
FDA
Valeant Pharmaceuticals Posts Phase 3 Results for Psoriasis Treatment
13 Dec 2016 //
DDDMAG
Sienna Biopharmaceuticals Acquires Creabilis plc
06 Dec 2016 //
PR NEWSWIRE
Allergan recalls some Tazorac acne gel
20 Oct 2016 //
FIERCE PHRAMA